Allain JP - Search Results

1

Current strategies on pathogen removal/inactivation: an overview.

Allain JP, Seghatchian J. Allain JP, et al. Transfus Apher Sci. 2001 Dec;25(3):195-7. doi: 10.1016/s1473-0502(01)00122-7. Transfus Apher Sci. 2001. PMID: 11846140 No abstract available.

2

Current strategies for the provision of safer plasma and its derivatives: an update.

Seghatchian J, Allain JP. Seghatchian J, et al. Among authors: allain jp. Transfus Apher Sci. 2001 Dec;25(3):185-7. doi: 10.1016/s1473-0502(01)00118-5. Transfus Apher Sci. 2001. PMID: 11846136 No abstract available.

3

Persistence of HTLV-I in blood components after leukocyte depletion.

Pennington J, Taylor GP, Sutherland J, Davis RE, Seghatchian J, Allain JP, Williamson LM. Pennington J, et al. Among authors: allain jp. Blood. 2002 Jul 15;100(2):677-81. doi: 10.1182/blood.v100.2.677. Blood. 2002. PMID: 12091364 Free article.

4

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

Allain JP, Bianco C, Blajchman MA, Brecher ME, Busch M, Leiby D, Lin L, Stramer S. Allain JP, et al. Transfus Med Rev. 2005 Apr;19(2):110-26. doi: 10.1016/j.tmrv.2004.11.005. Transfus Med Rev. 2005. PMID: 15852240 Free PMC article. Review.

5

Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.

Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP. Candotti D, et al. Among authors: allain jp. Transfusion. 2003 Feb;43(2):215-25. doi: 10.1046/j.1537-2995.2003.00308.x. Transfusion. 2003. PMID: 12559017

6

Occult hepatitis B virus infection.

Allain JP. Allain JP. Transfus Clin Biol. 2004 Feb;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. Transfus Clin Biol. 2004. PMID: 14980545 Review.

7

A European perspective on the management of donors and units testing positive for hepatitis B virus DNA.

Allain JP, Reesink HW, Lucey C. Allain JP, et al. Transfusion. 2006 Jul;46(7):1256-8. doi: 10.1111/j.1537-2995.2006.00885.x. Transfusion. 2006. PMID: 16836576 No abstract available.

8

Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.

Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP. Parsyan A, et al. Among authors: allain jp. Transfusion. 2006 Sep;46(9):1593-600. doi: 10.1111/j.1537-2995.2006.00952.x. Transfusion. 2006. PMID: 16965589

9

A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.

Wendel S, Levi JE, Biagini S, Candotti D, Allain JP. Wendel S, et al. Among authors: allain jp. Transfusion. 2008 Aug;48(8):1602-8. doi: 10.1111/j.1537-2995.2008.01723.x. Epub 2008 May 2. Transfusion. 2008. PMID: 18466175

10

Deferred donor care in a regional hospital blood center in Ghana.

Allain JP, Opare-Sem O, Sarkodie F, Rahman R, Owusu-Ofori S. Allain JP, et al. Transfusion. 2009 Apr;49(4):669-75. doi: 10.1111/j.1537-2995.2008.02055.x. Epub 2008 Jan 2. Transfusion. 2009. PMID: 19170991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page